Drugs / Hydroxycoloroquine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04853901 Comparator | Jul 2020 → Jan 2021 | COVID-19 | Ain Shams University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hydroxycoloroquine | “Hydroxycoloroquine 400mg twice on day 1 then 200mg tab twice 2-10 days” NCT04853901 ↗ |